U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06987838) titled 'Effect of Virtual Reality on Prostaglandin Levels in Adolescent Females With Primary Dysmenorrhea' on May 16.
Brief Summary: This study will be conducted to study the effect of virtual reality therapy on prostaglandin levels in adolescent females with primary dysmenorrhea.
Study Start Date: May 25
Study Type: INTERVENTIONAL
Condition:
Primary Dysmenorrhea
Intervention:
DRUG: Pharmacological treatment
All participants in the two groups will receive pharmacological treatment in the form of ibuprofen 400 mg, three times per day, during the first 2 days of menstruation, for 3 menstrual cycles.
OTHER: Virtual reality
The experime...